232 related articles for article (PubMed ID: 37840912)
1. Diagnosing multiple system atrophy: current clinical guidance and emerging molecular biomarkers.
Goolla M; Cheshire WP; Ross OA; Kondru N
Front Neurol; 2023; 14():1210220. PubMed ID: 37840912
[TBL] [Abstract][Full Text] [Related]
2. The potential of phosphorylated α-synuclein as a biomarker for the diagnosis and monitoring of multiple system atrophy.
Abdul-Rahman T; Herrera-Calderón RE; Ahluwalia A; Wireko AA; Ferreira T; Tan JK; Wolfson M; Ghosh S; Horbas V; Garg V; Perveen A; Papadakis M; Ashraf GM; Alexiou A
CNS Neurosci Ther; 2024 Apr; 30(4):e14678. PubMed ID: 38572788
[TBL] [Abstract][Full Text] [Related]
3. Efficient RT-QuIC seeding activity for α-synuclein in olfactory mucosa samples of patients with Parkinson's disease and multiple system atrophy.
De Luca CMG; Elia AE; Portaleone SM; Cazzaniga FA; Rossi M; Bistaffa E; De Cecco E; Narkiewicz J; Salzano G; Carletta O; Romito L; Devigili G; Soliveri P; Tiraboschi P; Legname G; Tagliavini F; Eleopra R; Giaccone G; Moda F
Transl Neurodegener; 2019; 8():24. PubMed ID: 31406572
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Value of Salivary Real-Time Quaking-Induced Conversion in Parkinson's Disease and Multiple System Atrophy.
Luan M; Sun Y; Chen J; Jiang Y; Li F; Wei L; Sun W; Ma J; Song L; Liu J; Liu B; Pei Y; Wang Z; Zhu L; Deng J
Mov Disord; 2022 May; 37(5):1059-1063. PubMed ID: 35278004
[TBL] [Abstract][Full Text] [Related]
5. Combined CSF α-SYN RT-QuIC, CSF NFL and midbrain-pons planimetry in degenerative parkinsonisms: From bedside to bench, and back again.
Compta Y; Painous C; Soto M; Pulido-Salgado M; Fernández M; Camara A; Sánchez V; Bargalló N; Caballol N; Pont-Sunyer C; Buongiorno M; Martin N; Basora M; Tio M; Giraldo DM; Pérez-Soriano A; Zaro I; Muñoz E; Martí MJ; Valldeoriola F
Parkinsonism Relat Disord; 2022 Jun; 99():33-41. PubMed ID: 35594661
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies.
Poggiolini I; Gupta V; Lawton M; Lee S; El-Turabi A; Querejeta-Coma A; Trenkwalder C; Sixel-Döring F; Foubert-Samier A; Pavy-Le Traon A; Plazzi G; Biscarini F; Montplaisir J; Gagnon JF; Postuma RB; Antelmi E; Meissner WG; Mollenhauer B; Ben-Shlomo Y; Hu MT; Parkkinen L
Brain; 2022 Apr; 145(2):584-595. PubMed ID: 34894214
[TBL] [Abstract][Full Text] [Related]
7. Discrimination of MSA-P and MSA-C by RT-QuIC analysis of olfactory mucosa: the first assessment of assay reproducibility between two specialized laboratories.
Bargar C; De Luca CMG; Devigili G; Elia AE; Cilia R; Portaleone SM; Wang W; Tramacere I; Bistaffa E; Cazzaniga FA; Felisati G; Legname G; Di Fonzo A; Xu R; Gunzler SA; Giaccone G; Eleopra R; Chen SG; Moda F
Mol Neurodegener; 2021 Dec; 16(1):82. PubMed ID: 34895275
[TBL] [Abstract][Full Text] [Related]
8. Clinical and Imaging Features of Multiple System Atrophy: Challenges for an Early and Clinically Definitive Diagnosis.
Watanabe H; Riku Y; Hara K; Kawabata K; Nakamura T; Ito M; Hirayama M; Yoshida M; Katsuno M; Sobue G
J Mov Disord; 2018 Sep; 11(3):107-120. PubMed ID: 30086614
[TBL] [Abstract][Full Text] [Related]
9. Neuropathology and molecular diagnosis of Synucleinopathies.
Koga S; Sekiya H; Kondru N; Ross OA; Dickson DW
Mol Neurodegener; 2021 Dec; 16(1):83. PubMed ID: 34922583
[TBL] [Abstract][Full Text] [Related]
10. Distinction of idiopathic Parkinson's disease from multiple-system atrophy by stimulation of growth-hormone release with clonidine.
Kimber JR; Watson L; Mathias CJ
Lancet; 1997 Jun; 349(9069):1877-81. PubMed ID: 9217760
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic utility of fluid biomarkers in multiple system atrophy: a systematic review and meta-analysis.
Cong S; Xiang C; Wang H; Cong S
J Neurol; 2021 Aug; 268(8):2703-2712. PubMed ID: 32162061
[TBL] [Abstract][Full Text] [Related]
12. Alpha-synuclein seeding shows a wide heterogeneity in multiple system atrophy.
Martinez-Valbuena I; Visanji NP; Kim A; Lau HHC; So RWL; Alshimemeri S; Gao A; Seidman MA; Luquin MR; Watts JC; Lang AE; Kovacs GG
Transl Neurodegener; 2022 Feb; 11(1):7. PubMed ID: 35125105
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in establishing fluid biomarkers for the diagnosis and differentiation of alpha-synucleinopathies - a mini review.
Singer W
Clin Auton Res; 2022 Aug; 32(4):291-297. PubMed ID: 35895157
[TBL] [Abstract][Full Text] [Related]
14. Potential clinical utility of multiple system atrophy biomarkers.
Jellinger KA
Expert Rev Neurother; 2017 Dec; 17(12):1189-1208. PubMed ID: 29023182
[TBL] [Abstract][Full Text] [Related]
15. [Expanding concept of clinical conditions and symptoms in multiple system atrophy].
Watanabe H; Riku Y; Nakamura T; Hara K; Ito M; Hirayama M; Yoshida M; Katsuno M; Sobue G
Rinsho Shinkeigaku; 2016 Jul; 56(7):457-64. PubMed ID: 27356737
[TBL] [Abstract][Full Text] [Related]
16. Multiple system atrophy.
Fanciulli A; Stankovic I; Krismer F; Seppi K; Levin J; Wenning GK
Int Rev Neurobiol; 2019; 149():137-192. PubMed ID: 31779811
[TBL] [Abstract][Full Text] [Related]
17. Multiple system atrophy.
Poewe W; Stankovic I; Halliday G; Meissner WG; Wenning GK; Pellecchia MT; Seppi K; Palma JA; Kaufmann H
Nat Rev Dis Primers; 2022 Aug; 8(1):56. PubMed ID: 36008429
[TBL] [Abstract][Full Text] [Related]
18. Diagnosing multiple system atrophy at the prodromal stage.
Xia C; Postuma RB
Clin Auton Res; 2020 Jun; 30(3):197-205. PubMed ID: 32232688
[TBL] [Abstract][Full Text] [Related]
19. Early recognition and diagnosis of multiple system atrophy: best practice and emerging concepts.
Marsili L; Giannini G; Cortelli P; Colosimo C
Expert Rev Neurother; 2021 Sep; 21(9):993-1004. PubMed ID: 34253122
[No Abstract] [Full Text] [Related]
20. An update on multiple system atrophy.
Stankovic I; Kuijpers M; Kaufmann H
Curr Opin Neurol; 2024 May; ():. PubMed ID: 38828714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
